Pictet Asset Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.01B Sell
2025
Q4
$1.43B Sell
2025
Q3
$1.4B Buy
2025
Q2
$1.16B Sell
2025
Q1
$1.43B Buy
2024
Q4
$1.4B Buy
2024
Q3
$1.54B Buy
2024
Q2
$1.38B Sell
2024
Q1
$1.49B Sell
2023
Q4
$1.39B Buy
2023
Q3
$1.28B Buy

Other funds holding TMO

Pictet Asset Management's TMO Position: Q1 2026 in Review

Pictet Asset Management reduced its Thermo Fisher Scientific (TMO) stake by 16% in Q1 2026, selling an estimated $218M and leaving 2,061,343 shares worth $1.01B. The position accounts for 1.07% of the portfolio, ranked #9.

Pictet Asset Management first reported a position in TMO in Q3 2023 and has held it in 11 quarters since. The position peaked at $1.54B in Q3 2024. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Pictet Asset Management held 2,061,343 shares of Thermo Fisher Scientific worth $1.01B as of Q1 2026.
  • Pictet Asset Management sold 400,813 Thermo Fisher Scientific shares in Q1 2026, an estimated $218M.
  • Thermo Fisher Scientific made up 1.07% of Pictet Asset Management's portfolio in Q1 2026, its #9 holding.
  • Pictet Asset Management first reported a position in Thermo Fisher Scientific in Q3 2023 and has held it in 11 quarters since.
  • Pictet Asset Management's Thermo Fisher Scientific position peaked at $1.54B in Q3 2024.
  • 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Pictet Asset Management's 13F filing for Q1 2026, filed 22 Apr 2026.